BMC Public Health

Table 2 Data characteristics by survey year and HIV status (%)

From: “Development in well-being and social function among Danish hemophilia patients with HIV: a three-wave panel study spanning 24 years”

		1988		2001		2012
		HIV⁺	HIV⁻	HIV⁺	HIV⁻	HIV⁺	HIV⁻
Age distribution	0–15 years	8	23	0	0	0	0
	16–24 years	26	21	6	6	6	6
	25–34 years	38	25	39	33	0	0
	35–44 years	11	21	39	39	44	33
	45–54 years	17	11	17	22	22	33
	55–88 years	0	0	0	0	28	28
	N	(53)	(53)	[18]	[18]	[18]	[18]
Factor use (per year)	0–25.000 units	8	12	0	0	6	6
	25.001–75.000 units	10	20	20	19	28	22
	75.001–125.000 units	22	16	35	38	11	22
	125.001–250.000 units	46	37	35	33	17	22
	250.001–500.000 units	8	12	10	5	33	22
	500.001- units	6	2	0	5	6	6
	N	(49)	(50)	[21]	[20]	[18]	[18]
Hepatitis B or C	Never	46^a	63^a	5	5	6	6
	Current or previous	54^a	37^a	95	95	94	94
	N	(46)	(46)	[21]	[21]	[18]	[18]
Bleeding episodes	No episodes	6	4	5	0	6	6
	1–10 episodes	34	53	53	50	61	33
	11–25 episodes	30	8	26	15	17	39
	26–50 episodes	19	21	16	25	11	11
	51+ episodes	11	15	0	10	6	11
	N	(53)	(53)	[20]	[19]	[18]	[18]
Severity of hemophilia	Severe	–	–	100	100	89	100
	Moderate			0	0	11	0
	N			[21]	[21]	[18]	[18]
Inhibitor (ever)	Never	77	84	81	90	67	67
	Current or previous	23	16	19	10	33	33
	N	(50)	(52)	[21]	[21]	[18]	[18]
Joint mobility	0	13	9	24	14	17	22
	1	17	17	10	5	6	22
	2	25	9	19	24	44	17
	3	15	21	10	24	17	22
	4	17	13	38	24	11	11
	5	12	30	0	10	6	6
	N

^aOnly HBV

Back to article page

ISSN: 1471-2458

Contact us

Submission enquiries: bmcpublichealth@biomedcentral.com
General enquiries: ORSupport@springernature.com